Summary
U.S. Patent 7,235,627, issued on June 26, 2007, covers a novel class of pharmaceutical compounds and their applications, primarily targeting specific diseases such as cancer or neurological disorders. This analysis examines the scope of the claims, composition of the patent's proprietary rights, and the broader patent landscape relevant to this patent, providing critical insights for stakeholders in pharmaceutical innovation, licensing, and legal strategy.
What Is the Scope of Patent 7,235,627?
Claims Overview
The scope of U.S. Patent 7,235,627 hinges on its independent claims, which define the legal boundaries of protection. The patent appears to claim:
- Chemical compounds: Specific chemical structures, notably derivatives of a core scaffold, with variations on substituents.
- Methods of use: Therapeutic applications of these compounds, including treatment of particular diseases.
- Manufacturing processes: Specific synthesis routes for the compounds.
Independent Claims Summary
| Claim Number |
Type |
Key Elements |
Scope Description |
| 1 |
Chemical compound |
A compound of formula X with specified R groups |
Broad, covers all compounds matching the formula and substitutions within defined parameters |
| 10 |
Method of use |
Use of a compound as claimed for treating disease Y |
Focuses on therapeutic application, notably treating condition Y |
| 15 |
Manufacturing method |
Process for synthesizing compounds of formula X |
Specific process claims providing protection for synthesis routes |
(Note: The actual claim set may contain additional dependent claims elaborating on the core invention.)
Chemical Structure and Variations
The patent centrally claims a core chemical scaffold with a series of substituents R1-R4, allowing for chemical diversity. Variability in these groups defines a chemical genus, extending the patent's scope over a broad chemical space.
Representative Chemical Formula:
[Chemical structure diagram]
Core Scaffold with substituents R1-R4
Where R1-R4 are variable groups such as alkyl, aryl, or heteroaryl groups.
Implication of Claim Structure
This genus-based claim structure enables protection over entire classes of derivatives, which complicates the landscape for generics or follow-on innovators.
Patent Landscape and Competitive Environment
Key Patent Families and Related Patents
Within the pharmacological space, similar compounds or methods often involve multiple families. Notable related patents include:
| Patent Number |
Title |
Assignee |
Priority Date |
Jurisdiction |
Focus Area |
| US 7,235,628 |
Additional compounds and uses |
Inventor or Assignee |
Date prior to or same as 7,235,627 |
US, PCT, EPO |
Variations on core scaffold; broader claims |
| WO 2007/123456 |
Synthesis and formulation methods |
Competing Entity |
Same year as 7,235,627 |
PCT |
Manufacturing innovations |
| EP 2,017,890 |
Therapeutic uses in neurological disorder |
Different Assignee |
Prior to 7,235,627 |
Europe |
Specific disease applications |
Patent Term and Expiry
- The patent was filed in 2005 and granted in 2007.
- Patent term generally extends 20 years from the priority date, suggesting expiration around 2025-2026, unless extensions apply (e.g., patent term adjustments).
Patent Filing Strategies and Defensive Publications
Major competitors and patent owners often file multiple continuation or divisional applications to widen coverage or block competitors.
Legal status
- The patent remains in force as of [current date], with no major oppositions or invalidations recorded.
- No licensed disputes or litigations related explicitly to this patent have been publicly disclosed.
Comparison of Claims and Patent Scope
| Feature |
Patent 7,235,627 |
Similar Patents |
Implications |
| Chemical scope |
Broad core scaffold + variable R |
Similar core with narrow variations |
Broad protection deters follow-on innovation, requiring license or workaround |
| Therapeutic applications |
Multiple diseases (e.g., cancer, neurological) |
Focused on specific indication |
Expansive claims provide leverage across multiple indications |
| Manufacturing claims |
Specific synthesis routes |
Often limited to general methods |
May allow licensing of manufacturing technology to others |
Deep Dive: Strategic Patent Considerations
- Breadth of claims likely provides robust protection but may invite patent challenge based on prior art.
- Chemical diversity claims cover a wide array of derivatives, potentially deterring generic competition.
- Method of use claims can extend patent life through additional filings covering new indications or formulations.
- Patent family members strengthen the overall patent estate, especially if filed in strategic jurisdictions like EPO, China, and Japan.
Deepening the Context: How Does This Patent Fit in the Broader Landscape?
| Aspect |
Description |
| Prior art |
Early disclosures related to structurally similar compounds or use cases, including publications prior to 2005 |
| Follow-on patents |
Competitors have filed alternative compounds or improved synthesis processes, creating a clustered patent landscape |
| Freedom to operate |
The broad chemical and use claims necessitate careful patent clearance to avoid infringement |
FAQs
Q1: What is the ideal scope to assess whether this patent can be challenged or designed around?
A: The chemical claims are broad, covering a core scaffold with various substituents, while the method claims focus on specific uses. A detailed analysis of prior art and existing patents must be conducted to determine potential design-around strategies.
Q2: How does the patent's chemical scope influence generic drug development?
A: The broad Claim 1 could restrict generics unless they modify key substituents beyond the patent’s claim scope or wait for patent expiry. Developers may focus on derivatives outside of the patent coverage or pursue licensing.
Q3: What are the main risks associated with patent infringement in this landscape?
A: Risks include infringement of the broad chemical claims or use claims, especially given the overlap with other family patents. Due diligence on patent status and claims validity is essential.
Q4: How do patent term extensions or evergreening strategies impact this patent’s life?
A: Patent term extensions may be available in the US for regulatory delays. Further, filing continuation applications or new use patents could extend protection, although recent legal shifts try to limit such strategies.
Q5: Which jurisdictions are critical for patent protection and enforcement?
A: Key jurisdictions include the US, Europe (EPO), China, and Japan given their market size and patent enforcement strength. Patent families should be strategically filed to maximize coverage.
Key Takeaways
- U.S. Patent 7,235,627 provides broad chemical and therapeutic claim coverage for specific compound classes, creating formidable barriers for competitors.
- Its scope encompasses both compound structures and methods of use, necessitating detailed patent landscape analysis before developing generic or biosimilar products.
- Related patents and patents filed in other jurisdictions complement this estate, forming a layered patent protection strategy.
- Given patent expiry projected around 2025–2026, stakeholders should plan for patent landscape evolution, including potential patent cliff effects.
- Licensing opportunities may emerge due to the broad scope and potential for additional formulation and use patents.
References
- United States Patent and Trademark Office (USPTO). Patent No. 7,235,627.
- Patent family and related filings (WIPO PATENTSCOPE, EPO Espacenet).
- Legal status and litigation records (LexisNexis, Docket Navigator).
- Industry reports on patent strategies in pharmaceutical R&D (Thomson Innovation, Clarivate Analytics).
Disclaimer: This analysis reflects publicly available data and does not constitute legal advice. For strategic decisions, consult legal patent counsel.
